GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (LTS:0HOY) » Definitions » Gross Profit

Boston Scientific (LTS:0HOY) Gross Profit : $10,972 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Boston Scientific Gross Profit?

Boston Scientific's gross profit for the three months ended in Sep. 2024 was $2,897 Mil. Boston Scientific's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was $10,972 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Boston Scientific's gross profit for the three months ended in Sep. 2024 was $2,897 Mil. Boston Scientific's Revenue for the three months ended in Sep. 2024 was $4,209 Mil. Therefore, Boston Scientific's Gross Margin % for the quarter that ended in Sep. 2024 was 68.83%.

Boston Scientific had a gross margin of 68.83% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Boston Scientific was 70.65%. The lowest was 64.59%. And the median was 69.75%.


Boston Scientific Gross Profit Historical Data

The historical data trend for Boston Scientific's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Gross Profit Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,554.00 6,403.00 8,177.00 8,726.00 9,895.00

Boston Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,426.00 2,578.00 2,647.00 2,850.00 2,897.00

Competitive Comparison of Boston Scientific's Gross Profit

For the Medical Devices subindustry, Boston Scientific's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Gross Profit distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Gross Profit falls into.



Boston Scientific Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Boston Scientific's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=14240 - 4345
=9,895

Boston Scientific's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=4209 - 1312
=2,897

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10,972 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Boston Scientific's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,897 / 4209
=68.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Boston Scientific  (LTS:0HOY) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Boston Scientific had a gross margin of 68.83% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Boston Scientific Gross Profit Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific Headlines

No Headlines